Related Experiment Video
Updated: Jun 10, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Absence of calcium channel alpha1C-subunit mutation in human atrial fibrillation
Jia-Lin Soon1, Liao Ping, Yeow-Leng Chua
1Department of Cardiothoracic Surgery, National Heart Center, National University of Singapore, Singapore. soon.jia.lin@nhcs.com.sg
Insights
This study found no mutations in the main pore-forming subunit of the L-type voltage-gated calcium channel in patients with atrial fibrillation. This suggests that genetic mutations in this specific channel subunit do not cause atrial fibrillation.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Genetics
Background:
- L-type voltage-gated calcium channels (CaV1.2) are crucial for cardiac function.
- Mutations or alternative splicing in CaV1.2 have been linked to sudden cardiac death and heart failure.
- Altered calcium channel activity is implicated in atrial fibrillation (AF).
Purpose of the Study:
- To investigate the association between mutations in the CaV1.2 alpha(1C) subunit and atrial fibrillation.
- To determine if genetic variations in this key channel subunit contribute to AF pathogenesis.
Main Methods:
- Human atrial tissue was collected from 16 cardiac surgery patients.
- DNA was extracted, amplified, and sequenced to screen for CaV1.2 alpha(1C) subunit mutations.
- Clinical data, including arrhythmia development, were prospectively collected.
Main Results:
- No mutations in the CaV1.2 alpha(1C) subunit were detected in any patient, irrespective of their cardiac rhythm.
- Four patients (25%) developed new-onset postoperative paroxysmal atrial fibrillation.
- The study did not find a correlation between AF and mutations in this specific channel subunit.
Conclusions:
- Loss-of-function mutations in the main pore-forming subunit of the L-type voltage-gated calcium channel are not associated with atrial fibrillation in this patient cohort.
- Other genetic or molecular mechanisms likely underlie the development of atrial fibrillation.
Abstract:
L-type voltage-gated calcium channel mutation or phenotypical variation resulting from alternative splicing has been associated with sudden arrhythmogenic death and heart failure. Changes in calcium current density, protein and mRNA expression have been associated with atrial fibrillation. We studied human atrium harvested from 16 cardiac surgery patients (coronary bypass and/or valve procedures) for mutation of Ca(v)1.2 alpha(1C) (the main pore-forming subunit of L-type voltage-gated calcium channel) for an association with atrial fibrillation. Seven patients had persistent atrial fibrillation and one was resuscitated from ventricular arrhythmia. Clinical data were collected and prospectively updated for the development of arrhythmia. Four (25%) patients had new-onset postoperative paroxysmal atrial fibrillation. DNA from all atrial specimens was amplified, extracted, and sequenced. The alpha(1C)-subunit mutation was absent in all specimens obtained from all patients, regardless of heart rhythm. This suggests that atrial fibrillation is not associated with loss-of-function mutation of the main pore-forming subunit of the L-type voltage-gated calcium channel.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

